Drug improves cognitive function in mouse model of Down syndrome, Stanford study says

(Stanford University Medical Center) An existing FDA-approved drug improves cognitive function in a mouse model of Down syndrome, according to a new study by researchers at the Stanford University School of Medicine.
Source: EurekAlert! - Medicine and Health - Category: Global & Universal Source Type: news